Gut Microbiome Testing: Evidence, Options and Alternatives
Gut Microbiome Test Comparison: Best & Most Comprehensive Options
Gut Microbiome Testing: What These Tests Can and Cannot Tell You
Gut microbiome testing has moved quickly from research laboratories into consumer kits that promise personalised insight into digestion, immunity and metabolism. The appeal is understandable: the gut microbiome is a large, diverse community of bacteria, fungi, viruses and other microorganisms that interacts with nearly every system in the body. What is often missing from the marketing is context about how much of that information is scientifically solid and how much remains exploratory.
This guide compares the main types of gut microbiome testing, the alternatives to standard stool sequencing and the leading commercial platforms. It also explains why gastroenterology societies such as the American Gastroenterological Association (AGA) and the American College of Gastroenterology (ACG), together with a recent international consensus statement on microbiome testing, do not recommend stool microbiome testing for routine clinical decision-making outside research.
Why Interest in Gut Microbiome Testing Keeps Growing
Research has linked gut microbial communities to conditions including inflammatory bowel disease, obesity, type 2 diabetes and some neurological and immune-related conditions. Most of these findings describe associations rather than proven cause-and-effect relationships, but they have generated strong interest from consumers, clinicians and researchers alike.
Three developments have accelerated that interest:
- Sequencing costs have fallen, making broad microbial profiling more affordable.
- Direct-to-consumer kits allow stool samples to be collected at home and posted to a laboratory.
- The personalised nutrition and supplement market has created demand for individual gut health scores and diet recommendations.
The result is a crowded market in which tests differ widely in methodology, depth and how their results are interpreted.
How Gut Microbiome Tests Work
Most microbiome tests analyse a stool sample, because stool carries a large share of the microbes that live in the lower digestive tract. The technology used determines what the report can realistically show.
Sequencing-Based Approaches
- 16S rRNA gene sequencing identifies bacteria using a conserved genetic marker. It gives a broad picture of bacterial groups, usually at genus level, and generally does not cover fungi, viruses or microbial function.
- Shotgun metagenomics sequences all the DNA in a sample, offering species-level and sometimes strain-level detail, plus information about fungi, viruses and archaea, as well as the functional potential encoded in microbial genes. It is more expensive and generates more complex data.
- Metatranscriptomic sequencing, used by some commercial providers, analyses microbial RNA to estimate which genes are actively expressed at the time of sampling. This can add a functional dimension, although interpretation relies heavily on proprietary models.
What a Report Typically Includes
- Relative abundance of bacterial groups, expressed as a percentage of the sample
- Diversity measures such as richness and evenness
- Ratios or scores that compare your sample with a reference group
- Diet, probiotic or lifestyle suggestions generated by the provider's algorithm
Clinical Utility of Gut Microbiome Testing: What Guidelines Say
This is the most important context for anyone comparing microbiome tests. Professional societies and regulators have concluded that stool microbiome testing is not yet ready for routine clinical use.
- The AGA has advised that microbiome-based testing should not guide clinical decisions outside research settings.
- The ACG and other gastroenterology organisations rely on validated tests, such as faecal calprotectin, stool pathogen panels and C. difficile testing, rather than broad microbiome profiling when investigating digestive symptoms.
- The recent international consensus statement on microbiome testing reached a similar conclusion, citing insufficient evidence that microbiome results improve diagnosis or treatment outcomes.
Several reasons explain this cautious position:
- Results are not standardised. Different laboratories, extraction methods and sequencing platforms can produce different profiles from the same sample.
- Reference ranges are poorly defined. There is no agreed healthy microbiome, because composition varies with age, diet, geography, medication and genetics.
- Clinical thresholds are missing. A result described as low or high usually reflects a comparison with a study population, not a diagnostic cut-off.
- Most interpretive algorithms are proprietary. Many consumer reports rely on models that have not been independently validated in peer-reviewed trials.
- Evidence of improved outcomes is limited. Few studies show that acting on a microbiome report changes health outcomes compared with standard care.
When Microbiome Testing May Be Useful
Microbiome testing may be appropriate in research settings, in clinical trials, or when a specialist uses it as one part of a broader evaluation. It can also be a reasonable educational tool for people who understand that the output is exploratory rather than diagnostic.
It is not, however, a replacement for validated clinical tests. For example, suspected C. difficile infection, inflammatory bowel disease monitoring and coeliac disease assessment each have their own established pathways. If symptoms are persistent or concerning, a clinician can decide which tests are appropriate.
Limitations to Keep in Mind Before Ordering a Test
- Microbiome composition can shift within days in response to food, travel, stress, alcohol, antibiotics and illness, so a single sample is a snapshot rather than a fixed profile.
- Test results rarely change clinical management, and in some cases may encourage unnecessary supplements, restrictive diets or anxiety.
- Consumer microbiome tests are generally not covered by health insurance, because they are usually classified as elective wellness products rather than medically necessary diagnostics.
- Stool sample handling, shipping time and storage conditions can all influence results.
None of this makes microbiome testing worthless. It means the technology is best understood today as an educational and research tool, not a diagnostic substitute for a clinician's assessment.
Alternatives and Complementary Approaches to Standard Microbiome Tests
If the goal is to understand gut function rather than simply list which bacteria are present, several alternative and complementary approaches are available. Each answers a different question, and each has its own evidence base and limitations.
Metabolomics: Measuring What Gut Microbes Actually Produce
Metabolomics analyses the small molecules produced by microbial metabolism, including short-chain fatty acids, bile acids and other compounds that can influence host physiology.
- Advantages: focuses on microbial activity rather than presence, and can capture effects that composition data alone would miss.
- Considerations: metabolite levels fluctuate with recent diet, medication and sampling time, and standardised reference ranges remain limited.
Proteomics: Profiling Microbial and Host Proteins
Proteomics studies proteins in a sample, providing information about microbial and human molecular activity.
- Benefits: can reveal host-microbe interactions and functional pathways that DNA-based tests do not capture.
- Limitations: requires specialised laboratory infrastructure and expertise, so it remains largely a research tool rather than a consumer option.
Breath Testing: A Non-Invasive Functional Assessment
Hydrogen and methane breath tests measure gases produced when gut microbes ferment carbohydrates. They are used in gastroenterology to investigate small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption.
- Pros: non-invasive, relatively inexpensive and accepted in specific clinical contexts.
- Limitations: results depend on test protocol and preparation, can be affected by other conditions, and provide little information about overall microbiome composition.
Culture-Based Microbiology
Culture-based methods grow and identify live bacteria from a stool sample.
- Strengths: allow functional testing of isolated strains and antibiotic susceptibility testing.
- Limitations: many anaerobic and fastidious gut microbes cannot be cultured easily, and the approach is labour-intensive and difficult to scale.
Host Immune and Inflammatory Markers
Markers such as faecal calprotectin, cytokines and antibodies reflect immune and inflammatory activity in the gut.
- Strengths: calprotectin in particular is a validated clinical test used to help distinguish inflammatory bowel disease from irritable bowel syndrome.
- Limitations: these markers describe the host response rather than the microbiome itself, and are not a substitute for microbial profiling.
Practical Alternatives: Structured Diet Trials and Symptom Tracking
For many people, the most useful alternative is not a laboratory test at all. A structured trial, for example gradually increasing fibre diversity, testing a specific probiotic, or working through a supervised elimination and reintroduction plan, combined with a symptom and stool diary, can generate personally relevant information at low cost and low risk.
This approach does not explain microbial mechanisms, and its evidence base varies by condition, but it often produces more actionable insight than a one-off microbiome report.
When a Clinical Test Is More Appropriate
Microbiome testing should not delay proper assessment of persistent or concerning digestive symptoms. Blood in the stool, unexplained weight loss, anaemia, fever or a sudden change in bowel habits lasting more than a few weeks warrant medical evaluation rather than a consumer test.
For these situations, clinicians may use targeted, validated tests rather than broad microbiome profiling. The choice depends on the symptoms, medical history and physical examination.
Gut Microbiome Test Comparison: Best & Most Comprehensive Options
Comparing Popular Commercial Gut Microbiome Testing Platforms
Consumer microbiome testing companies differ in the technology they use, the data they report and the strength of evidence behind their recommendations. The descriptions below are a starting point for comparison rather than an endorsement, and none of these platforms is currently positioned as a diagnostic tool.
Viome
Viome uses metatranscriptomic sequencing, analysing microbial RNA to estimate which microbial functions are active at the time of sampling. Reports include functional scores, food lists and supplement suggestions.
- Strengths: adds a functional dimension and covers more than bacteria alone.
- Limitations: higher price point; the scoring and recommendation models are proprietary and have limited independent peer-reviewed validation; not covered by insurance.
DayTwo
DayTwo combines metagenomic sequencing with clinical and dietary data to predict individual blood glucose responses and build personalised nutrition plans, with a focus on metabolic health.
- Strengths: built around a defined clinical outcome, glycaemic response, and supported by published research in that area.
- Considerations: a specialised service for metabolic management rather than a general microbiome profile, so it will not suit every question.
Thryve (now Ombre)
Thryve, now operating as Ombre, uses 16S sequencing together with a microbiome scoring model and offers probiotic and dietary suggestions plus repeat testing over time.
- Strengths: consumer-friendly interface and trend tracking between samples.
- Limitations: bacterial analysis only, with limited functional insight.
American Gut Project
The American Gut Project is a citizen-science initiative that uses 16S sequencing and lets participants compare their sample with a large global dataset.
- Strengths: low cost, transparent research framing and a contribution to open science.
- Limitations: individualised clinical guidance is limited, and the volume of comparative data can be difficult to interpret without support.
uBiome (now YaqDNA Technologies)
uBiome was one of the best-known early consumer providers, using 16S sequencing to report bacterial diversity and dietary suggestions. Its consumer operations ended in 2019 following legal and regulatory difficulties, and its assets were later acquired.
That episode is a useful reminder to check a provider's corporate stability, data policies and laboratory credentials before sending a sample.
EverlyWell
EverlyWell offers a gut microbiome test within a broader menu of at-home health tests. Its microbiome panel is based on bacterial sequencing and is presented as a wellness tool, sometimes with clinician review of results depending on the region.
- Strengths: established consumer testing infrastructure and a wide range of complementary panels.
- Limitations: bacterial-focused reporting, general wellness positioning and no demonstrated diagnostic role.
How the Main Platforms Differ
- Viome and DayTwo lean on functional or metabolic data rather than composition alone.
- Thryve/Ombre and EverlyWell rely mainly on 16S bacterial profiling.
- The American Gut Project is research-oriented, with less individual guidance.
Does the Most Advanced Test Mean the Best Test?
A test that generates more data is not automatically more useful. Metatranscriptomics and multi-omic approaches produce richer information, but that information still has to be interpreted, and no consumer platform has shown that its report changes clinical outcomes. The best test is the one that matches a clear question, uses transparent methods and does not overstate what the result can support.
How to Choose a Gut Microbiome Test, and How to Read the Results
Because the platforms differ so much, the most useful starting point is not which test is best, but what you want to find out.
Start With the Question You Want Answered
- General curiosity about gut bacteria: a basic 16S-based test or a research project may be enough.
- Interest in microbial function: look for metagenomic or metatranscriptomic approaches, and read how the provider interprets that data.
- A specific clinical concern such as persistent diarrhoea, bloating or suspected malabsorption: speak to a clinician first, because validated tests may be more appropriate.
- Metabolic goals such as blood sugar management: a service built around that outcome, such as DayTwo, may fit better than a general microbiome panel.
Check the Methodology and Scope
Find out whether the test uses 16S sequencing, shotgun metagenomics, metatranscriptomics or a combination, and whether it covers fungi, viruses and archaea as well as bacteria. Broader methods usually cost more and produce more complex reports.
Look for Evidence and Transparency
Prefer providers that publish their methods, cite peer-reviewed research and explain the limits of their own reports. Be cautious of claims that a test can diagnose a condition, replace medical assessment or predict disease. Reputable companies also explain how they handle samples, how long they store data and who can access it.
Understand What the Report Can and Cannot Support
- Relative abundance figures describe proportions within a single sample, not absolute numbers of bacteria.
- Scores comparing you with a reference group are not clinical thresholds.
- Recommendations are generated by an algorithm, which may be based on population data rather than your individual response.
- A single result is a snapshot, because microbiome composition changes over days and weeks.
Privacy, Data Use and Sample Handling
Microbiome data is sensitive. Check whether samples are destroyed after analysis, whether data is shared with research partners or third parties, whether you can request deletion, and how long shipping takes, since transit time can affect sample quality.
Cost, Insurance and Repeat Testing
Consumer microbiome tests typically range from under $100 for basic sequencing to several hundred dollars for multi-omic analysis, and are generally not reimbursed by insurance because they are classified as wellness products. Some clinically validated stool tests, such as faecal calprotectin or stool pathogen panels, may be covered when ordered by a clinician for a specific medical reason.
Repeat testing is often marketed as progress tracking, but because composition fluctuates naturally, retesting within a few weeks usually adds little meaningful information. If a clinician has recommended monitoring for a specific condition, follow that advice instead of a consumer retest schedule.
Interpreting Results Without Over-Interpreting Them
A microbiome report can be interesting and sometimes motivating, but it is not a diagnosis. Before making significant changes, such as restrictive diets, multiple supplements or long-term probiotic protocols, consider discussing the report with a clinician or dietitian who can place it alongside your symptoms, medical history and other test results.
Frequently Asked Questions About Microbiome Testing
Are gut microbiome tests reliable and accurate?
Sequencing itself is a mature technology, and well-run laboratories can produce broadly reproducible results. The difficulty lies in interpretation: there is no standard reference range for a healthy microbiome, results vary between laboratories and methods, and most consumer scoring models have not been independently validated. This is why professional guidelines do not recommend stool microbiome testing for clinical decisions, and why a report is best treated as exploratory information rather than a diagnosis.
Will insurance pay for a gut microbiome test?
In most cases, no. Consumer microbiome kits are usually classified as elective wellness products rather than medically necessary diagnostics, so insurers generally do not reimburse them. Some clinically validated stool tests, such as faecal calprotectin, stool pathogen panels or C. difficile testing, are covered when ordered by a clinician for a specific medical reason. It is worth checking your policy and asking your provider directly.
Which gut microbiome test is the best or most advanced?
There is no single best test, because best depends on the question being asked. For broad bacterial composition, a 16S-based test is usually sufficient. For species-level and functional detail, shotgun metagenomics or metatranscriptomics offer more depth, at a higher price and with greater interpretive uncertainty. For research participation, citizen-science projects such as the American Gut Project are transparent and affordable. The most advanced option is not automatically the most useful, and no consumer test is currently validated as a diagnostic tool.
How do Viome and EverlyWell compare?
Viome centres on metatranscriptomic sequencing and produces proprietary functional scores with food and supplement suggestions. EverlyWell offers a bacterial sequencing panel as part of a wider range of at-home tests, presented mainly as general wellness information. Both are consumer-oriented products rather than clinical diagnostics, and neither is typically reimbursed by insurance.
What are the signs of an unhealthy gut microbiome?
There is no reliable symptom checklist that maps onto a specific microbiome profile. Symptoms such as bloating, gas, irregular bowel habits, fatigue or food intolerance are common and non-specific, and can have many causes, including diet, medication, stress, infection or a diagnosed digestive condition. A microbiome report cannot currently confirm or rule out these causes, so persistent symptoms are best discussed with a healthcare professional.
How long does it take to reset the gut microbiome?
There is no fixed reset timeline, because the microbiome responds to diet, illness, antibiotics and environment in different ways for different people. Some changes, such as a shift after antibiotics, may be measurable within days to weeks, while broader recovery can take longer and may not return to the exact previous composition. A single test result cannot reliably tell you when a reset is complete. Focus on gradual, sustainable habits such as fibre diversity, fermented foods where tolerated, sleep and stress management rather than a fixed timeline.
Where Gut Microbiome Testing May Be Heading
The field is moving quickly, and several directions could change how these tests are used:
- Multi-omic integration, combining genomic, transcriptomic, proteomic and metabolomic data into a single profile.
- Machine learning models that identify patterns associated with health outcomes, provided they are validated on independent datasets.
- Point-of-care and wearable-style devices that could assess microbial activity closer to real time.
- Microbiome-directed therapies, including defined bacterial consortia, bacteriophages and faecal microbiota transplantation, guided by microbial profiling in research settings.
- Regulatory and standardisation efforts covering laboratory methods, data privacy and the claims made to consumers.
These developments are promising, but they describe where the science may go rather than what today's tests can deliver.
The Bottom Line
Gut microbiome testing is a genuinely interesting window into a complex ecosystem, and the range of options, from 16S sequencing and shotgun metagenomics to metabolomics, breath tests and immune markers, means there is more choice than ever. What these approaches share is an important limitation: none is currently recommended for routine clinical decision-making, and none replaces a proper medical assessment.
A sensible approach is to match the test to a specific question, weigh the evidence behind the provider's interpretation, keep expectations realistic and treat results as one input among many. If you have persistent digestive symptoms, start with a clinician rather than a kit.
Find more details about Gut Microbiome Test Comparisons
You can find more information on the related topics below.
Read more: Comparing Gut Microbiome Tests, Reliability and Clinical Guidance
Your Gut Has a Story. Read It — Then Fix Potential Problems
Full microbiome sequencing + Gut Health Index. Metabolic pathways, diversity, keystone species. Personalized plans available (diet, supplements, diary, recipes). EU lab + Maastricht University spin-off + GDPR-safe.